Substitute for trelegy?

A direct one-inhaler substitute for Trelegy Ellipta isn’t the same everywhere. Trelegy is a triple therapy (ICS/LABA/LAMA) in one device, and in the U.S. there isn’t another single-inhaler triple option approved. Some regions do have a different single-inhaler triple (Trimbow: budesonide/formoterol/glycopyrronium), but availability depends on country and insurer.

What you can consider (often with your clinician):
- Two-inhaler approach (ICS/LABA + LAMA):
- Breo Ellipta (fluticasone furoate/vilanterol) daily + Incruse Ellipta (umeclidinium) daily
- Seretide (fluticasone propionate/salmeterol) twice daily + Incruse Ellipta daily
- Symbicort (budesonide/formoterol) twice daily + Incruse Ellipta daily
This can achieve similar triple-therapy effect using two devices.

- If you’re in a region where a single-inhaler triple like Trimbow is approved, your clinician can discuss that option (budesonide/formoterol/glycopyrronium).

Important: Do not stop Trelegy abruptly. Switches should be guided by a clinician, and insurance/cost considerations vary.

If you’d like, tell me your country and why you’re seeking a substitute (cost, tolerance, access, etc.), and I can tailor some specific options and pros/cons for you.